Review |
From the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
Correspondence to Henry N. Ginsberg, MD, Department of Medicine, PH 10305, Columbia University College of Physicians and Surgeons, 630 West 168th St, New York, NY 10032. E-mail hng1{at}columbia.edu
This Review is part of a thematic series on Adipocyte Signaling in the Cardiovascular System, which includes the following articles:
Adipose Tissue, Inflammation and Cardiovascular Disease
Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin Resistant Adipose Tissue
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Adipocyte Signaling and the Vasculature
PPARgamma Activation and Effects on the Vasculature
Phillip Scherer Guest Editor
For many years adipose tissue was viewed as the site where excess energy was stored, in the form of triglycerides (TGs), and where that energy, when needed elsewhere in the body, was released in the form of fatty acids (FAs). Recently, it has become clear that when the regulation of the storage and release of energy by adipose tissue is impaired, plasma FA levels become elevated and excessive metabolism of FA, including storage of TGs, occurs in nonadipose tissues. Most recently, work by several laboratories has made it clear that in addition to FA, adipose tissue communicates with the rest of the body by synthesizing and releasing a host of secreted molecules, collectively designated as adipokines. Several recent reviews have described how these molecules, along with FA, significantly effect total body glucose metabolism and insulin sensitivity. Relatively little attention has been paid to the effects of adipokines on lipid metabolism. In this review, we will describe, in detail, the effects of molecules secreted by adipose tissue, including FA, leptin, adiponectin, resistin, TNF-
, IL-6, and apolipoproteins, on lipid homeostasis in several nonadipose tissues, including liver, skeletal muscle, and pancreatic ß cells.
Key Words: lipids fatty acids adipose tissue insulin resistance cytokines
This article has been cited by other articles:
![]() |
J. Butler, A. Kalogeropoulos, V. Georgiopoulou, N. de Rekeneire, N. Rodondi, A. L. Smith, U. Hoffmann, A. Kanaya, A. B. Newman, S. B. Kritchevsky, et al. Serum Resistin Concentrations and Risk of New Onset Heart Failure in Older Persons: The Health, Aging, and Body Composition (Health ABC) Study Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1144 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez-Periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong, E. Moran-Salvador, E. Titos, M. Martinez-Clemente, M. Lopez-Parra, V. Arroyo, et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins FASEB J, June 1, 2009; 23(6): 1946 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikubo, T. Wada, K. Fukui, M. Ishiki, H. Ishihara, T. Asano, H. Tsuneki, and T. Sasaoka Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-{alpha}-induced insulin resistance in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E157 - E164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Ferranti and D. Mozaffarian The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic Consequences Clin. Chem., June 1, 2008; 54(6): 945 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nelson, N. Sattar, D. J. Freeman, J. D. Walker, and R. S. Lindsay Inflammation and Endothelial Activation Is Evident at Birth in Offspring of Mothers With Type 1 Diabetes Diabetes, November 1, 2007; 56(11): 2697 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Krusinova, M Klementova, J Kopecky, P Wohl, L Kazdova, P Mlejnek, M Pravenec, M Hill, and T Pelikanova Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects Eur. J. Endocrinol., October 1, 2007; 157(4): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fantuzzi and T. Mazzone Adipose Tissue and Atherosclerosis: Exploring the Connection Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 996 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Brake, E. O. Smith, H. Mersmann, C. W. Smith, and R. L. Robker ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1232 - C1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chen, L. Liu, Y. Zhang, H. N. Ginsberg, and Y.-H. Yu Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue Diabetes, December 1, 2005; 54(12): 3379 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. van der Vleuten, L. J. H. van Tits, M. den Heijer, H. Lemmers, A. F. H. Stalenhoef, and J. de Graaf Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile J. Lipid Res., November 1, 2005; 46(11): 2398 - 2404. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |